Financial Daily from THE HINDU group of publications
Saturday, Oct 30, 2004
Financial Daily from THE HINDU group of publications Saturday, Oct 30, 2004 |
||
|
|
||
|
Industry & Economy
-
Health Marketing - New Products & Services Serum Institute launches indigenous rabies vaccine Our Bureau
Mumbai , Oct. 29 SERUM Institute of India Ltd has launched the first locally developed Human Diploid Cell (HDC) rabies vaccine "Rabivax". The new product assumes significance, given that India carries about 40 per cent of the global load of rabies cases. The HDC rabies vaccine is more stable and the quality of the vaccine would not get affected if there were a problem with refrigeration during storage, said Dr Cyrus S. Poonawalla, Chairman of the Pune-based institute. HDC vaccines are considered to be better than tissue culture vaccines, he said and added that they offer better protection. Company officials vouched for the vaccine's safety standards and added that it had minimum adverse reactions. Priced at Rs 293 per dose, Rabivax is comparable to other products in the market, such as the vaccine from Aventis, Dr Poonawalla said. He said the institute was scaling up its production to match the demand from local and global markets. "We have orders to sell the vaccine at double the price abroad. For the last 15 years, we have been distributing Aventis' vaccine at $15 per dose. Our vaccines are of better quality and more stable," he said. The size of the market for rabies vaccines is about Rs 150 crore, he said and added that the Rs 550-crore Institute was looking to export Rabivax to Egypt, Thailand and Sri Lanka.
More Stories on : Health | New Products & Services | Maharashtra
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|